Palobiofarma Receives Venture Philanthropy Award from Foundation for Prader-Willi Research to Advance PBF-999 Development for Prader-Willi Syndrome Treatmenta

[Pamplona, Covina] – The Foundation for Prader Willi Research (FPWR) has provided a new venture philanthropy award, in the form of a convertible loan, to Palobiofarma S.L., a Spanish biopharmaceutical company focused on developing innovative treatments for serious diseases.

Scroll to Top